Literature DB >> 21557210

CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.

Rodolfo Bianchini1, Onelia Bistoni, Alessia Alunno, Maria Grazia Petrillo, Simona Ronchetti, Paolo Sportoletti, Elena Bartoloni Bocci, Giuseppe Nocentini, Roberto Gerli, Carlo Riccardi.   

Abstract

Treg subsets play a role in sustaining peripheral tolerance, are characterized by markers such as forkhead winged-helix transcription factor (FOXP3) and CD25, and produce suppressive cytokines, such as IL-10 and TGF-β. Glucocorticoid-induced TNF receptor family-related (GITR) protein has been suggested to regulate Treg activity in mice. The aim of our study was to investigate GITR expression in human CD4(+) T lymphocytes and its possible role in Treg function. Results indicate that a subset of CD4(+) T cells in the peripheral blood expresses GITR and low levels of CD25 (CD4(+) CD25(low) GITR(+) ). These cells show Treg features as they express FOXP3, IL-10, TGF-β and are anergic but, as opposed to natural Tregs, express low levels of CTLA-4 and are CD127(high) . CD4(+) CD25(low) GITR(+) cells represent a low percentage of the CD4(+) T-cell population (0.32-1.74%) and are mostly memory cells. Functional experiments demonstrated that CD4(+) CD25(low) GITR(+) cells have relevant suppressive activity that depends on TGF-β. Moreover, an anti-GITR Ab inhibited their suppressive activity, as observed in CD4(+) CD25(+) murine Tregs. Taken together, these data indicate that human CD4(+) CD25(low) GITR(+) cells represent a distinct Treg subpopulation.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557210     DOI: 10.1002/eji.201040943

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.

Authors:  Luigi Cari; Giuseppe Nocentini; Graziella Migliorati; Carlo Riccardi
Journal:  Oncoimmunology       Date:  2017-11-09       Impact factor: 8.110

2.  Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Georgi Vasilev; Mariana Ivanova; Ekaterina Ivanova-Todorova; Kalina Tumangelova-Yuzeir; Ekaterina Krasimirova; Rumen Stoilov; Dobroslav Kyurkchiev
Journal:  Rheumatol Int       Date:  2019-04-03       Impact factor: 2.631

Review 3.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

Review 4.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Maria Grazia Petrillo; Carlo Riccardi
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 5.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population.

Authors:  Meghan E Free; Donna O'Dell Bunch; Julie Anne McGregor; Britta E Jones; Elisabeth A Berg; Susan L Hogan; Yichun Hu; Gloria A Preston; J Charles Jennette; Ronald J Falk; Maureen A Su
Journal:  Arthritis Rheum       Date:  2013-07

7.  Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons.

Authors:  Maria Florencia Quiroga; Matias Tomas Angerami; Natalia Santucci; Diego Ameri; Jose Luis Francos; Jorge Wallach; Omar Sued; Pedro Cahn; Horacio Salomón; Oscar Bottasso
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

8.  Genetically Modified Lactococcus lactis for Delivery of Human Interleukin-10 to Dendritic Cells.

Authors:  Inge L Huibregtse; Sebatian A Zaat; Martien L Kapsenberg; Maria A Sartori da Silva; Maikel P Peppelenbosch; Sander J H van Deventer; Henri Braat
Journal:  Gastroenterol Res Pract       Date:  2011-07-27       Impact factor: 2.260

9.  IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of  T Cell Activation.

Authors:  Hanna Bendfeldt; Manuela Benary; Tobias Scheel; Kerstin Steinbrink; Andreas Radbruch; Hanspeter Herzel; Ria Baumgrass
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

Review 10.  Regulatory T cells in HIV infection: can immunotherapy regulate the regulator?

Authors:  Mohammad-Ali Jenabian; Petronela Ancuta; Norbert Gilmore; Jean-Pierre Routy
Journal:  Clin Dev Immunol       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.